Here are 16 key notes on orthopedic and spine device companies over the past week.
Zimmer Biomet plans to acquire majority stake in MedTech, a France-based company focused on the ROSA Robotic System for brain and spine surgery.
Zimmer Biomet and Indo UK Institutes of Health announced plans for a multi-year collaboration.
MedTech reported a 73 percent increase in revenue for the full year 2016 over $7.2 million in 2015.
Medtronic received the first-ever FDA clearance for cement-augmented pedicle screws in the CD Horizon Fenestrated Screws.
The FDA cleared Medtronic's Prestige LP Cervical Disc for two-level applications.
Medtronic expanded its oblique lateral interbody fusion platform with its new Pivox Oblique Lateral Spinal System with Lateral Plate for OLIF25 and Divergence-L Anterior/Oblique Lumbar Fusion System for OLIF51.
Medtronic announced its goal is to generate $40 billion in free cash flow over the next five years, with half returned to shareholders as dividends and buybacks.
Johnson & Johnson reported DePuy Synthes' orthopedics sales worldwide was $2.3 billion in the second quarter of 2016.
Life Spine reported its revenue increased 50 percent in the second quarter of 2016, compared to the same period in 2015.
Arthrex is expanding to create 560 jobs at its corporate campus in Naples, Fla.
InVivo Therapeutics added Ben Taub Hospital in Houston as a clinical site for the INSPIRE study.
Spineart's new JULIET Ti lumbar interbody systems received the CE Mark.
IlluminOss Medical completed enrollment in its first U.S. clinical trial for its IlluminOss System.
Data from two new clinical studies on the Mazor robotic technology were presented at the International Meeting on Advanced Spine Techniques in Washington, DC.
A new multicenter retrospective study with a prospective evaluation of SI-BONE's iFuse system shows how minimally invasive sacroiliac joint surgery can impact the appropriately-selected patients.
DePuy Synthes and Stryker lead the Australian bone graft substitutes market.